A-118 SCAT5 Cognitive Screening Performance by Athlete Sex: Implications for Clinical Interpretation

Abstract Objective To examine sex differences in performance on SCAT-5 Cognitive Screening indices. Method A multisport baseline sample was composed of 727 uninjured Division I collegiate athletes (52% female) who were administered the SCAT5 before the 2017–2018 seasons. Repeat baseline testing was completed by 273 uninjured athletes (48% female) at 1 year (days M = 352.56;SD = 56.03) who were then included in the repeated measure analyses. SCAT5 Cognitive Screening indices included the SAC Total, Immediate Recall, and Delayed Recall, at both baseline testing sessions. Results A 3-factor mixed repeated measure MANOVA (SCAT5 Cognitive Index x baseline administration x sex) was completed. Significant between-subject differences were noted across SCAT5 measures and baselines by sex (F(1, 271) = 26.38,p